8
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Pharmacologic differentiation of inflammation and fibrosis in the rat bleomycin model.

      Read this article at

      ScienceOpenPublisherPubMed
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The model most often used to study the pathogenesis of pulmonary fibroses is the bleomycin (BLM)-induced lung fibrosis model. Several treatments have been efficacious in this model, but not in the clinic.

          Related collections

          Author and article information

          Journal
          Am J Respir Crit Care Med
          American journal of respiratory and critical care medicine
          American Thoracic Society
          1073-449X
          1073-449X
          Apr 01 2006
          : 173
          : 7
          Affiliations
          [1 ] Department of Pulmonary Research, Boehringer Ingelheim Pharma GmbH & Co., KG, Biberach an der Riss, Germany.
          Article
          200505-717OC
          10.1164/rccm.200505-717OC
          16415276
          997f4759-8978-46f9-9681-ba4e778c1ae0
          History

          Comments

          Comment on this article